Overview

Pharmacological Intervention in Depression After Traumatic Brain Injury

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with venlafaxine reduces symptoms of depression in persons with traumatic brain injury.
Phase:
Phase 4
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborator:
U.S. Department of Education
Treatments:
Venlafaxine Hydrochloride